世界の糖尿病黄斑浮腫治療市場規模・現状・予測2021-2027

【英語タイトル】Global Diabetic Macular Edema Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR1834)・商品コード:QY21APR1834
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、糖尿病黄斑浮腫治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(レーザー光凝固療法、薬物療法、ベバシズマブ、ラニビズマブ、トリアムシノロン)、用途別市場規模(病院、眼科クリニック、研究所、委託研究機関)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・糖尿病黄斑浮腫治療の市場動向
・企業の競争状況、市場シェア
・糖尿病黄斑浮腫治療の種類別市場規模(レーザー光凝固療法、薬物療法、ベバシズマブ、ラニビズマブ、トリアムシノロン)
・糖尿病黄斑浮腫治療の用途別市場規模(病院、眼科クリニック、研究所、委託研究機関)
・糖尿病黄斑浮腫治療の北米市場規模2016-2027(アメリカ、カナダ)
・糖尿病黄斑浮腫治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・糖尿病黄斑浮腫治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・糖尿病黄斑浮腫治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・糖尿病黄斑浮腫治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Genentech、Novartis、GlaxoSmithKline、Eyetech Pharmaceuticals、Alimera Sciences)
・結論
【レポートの概要】

Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema.
Increasing prevalence of diabetes in the prime factor driving growth of global diabetic macular edema therapeutics market. The prevalence of diabetic macular edema is higher in type 2 diabetes patients than in type 1 diabetes patients. As per study conducted by University Hospital Sant Joan de Reus Spain, the incidence of diabetic macular edema is in the range of 0.9%-2.3%, annually, across the globe. Besides this, substantial R&D investment by pharmaceutical companies and advancement in ophthalmic surgrey techniques are some other factors fueling the growth of global diabetic macular edema treatment market.

Market Analysis and Insights: Global Diabetic Macular Edema Treatment Market
The global Diabetic Macular Edema Treatment market size is projected to reach US$ 3259.5 million by 2026, from US$ 3009.3 million in 2019, at a CAGR of 1.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Macular Edema Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Macular Edema Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Macular Edema Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Macular Edema Treatment market.

Global Diabetic Macular Edema Treatment Scope and Market Size
Diabetic Macular Edema Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Macular Edema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Laser Photocoagulation Therapy
Pharmacological Therapy
Bevacizumab
Ranibizumab
Triamcinolone

Segment by Application
Hospitals
Ophthalmic Clinics
Research Institutes
Contract Research Organizations

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genentech
Novartis
GlaxoSmithKline
Eyetech Pharmaceuticals
Alimera Sciences

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Laser Photocoagulation Therapy
1.2.3 Pharmacological Therapy
1.2.4 Bevacizumab
1.2.5 Ranibizumab
1.2.6 Triamcinolone
1.3 Market by Application
1.3.1 Global Diabetic Macular Edema Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ophthalmic Clinics
1.3.4 Research Institutes
1.3.5 Contract Research Organizations
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Macular Edema Treatment Market Perspective (2016-2027)
2.2 Diabetic Macular Edema Treatment Growth Trends by Regions
2.2.1 Diabetic Macular Edema Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Macular Edema Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Macular Edema Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Macular Edema Treatment Industry Dynamic
2.3.1 Diabetic Macular Edema Treatment Market Trends
2.3.2 Diabetic Macular Edema Treatment Market Drivers
2.3.3 Diabetic Macular Edema Treatment Market Challenges
2.3.4 Diabetic Macular Edema Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Macular Edema Treatment Players by Revenue
3.1.1 Global Top Diabetic Macular Edema Treatment Players by Revenue (2016-2021)
3.1.2 Global Diabetic Macular Edema Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Macular Edema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Macular Edema Treatment Revenue
3.4 Global Diabetic Macular Edema Treatment Market Concentration Ratio
3.4.1 Global Diabetic Macular Edema Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Macular Edema Treatment Revenue in 2020
3.5 Diabetic Macular Edema Treatment Key Players Head office and Area Served
3.6 Key Players Diabetic Macular Edema Treatment Product Solution and Service
3.7 Date of Enter into Diabetic Macular Edema Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Macular Edema Treatment Breakdown Data by Type
4.1 Global Diabetic Macular Edema Treatment Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Macular Edema Treatment Forecasted Market Size by Type (2022-2027)

5 Diabetic Macular Edema Treatment Breakdown Data by Application
5.1 Global Diabetic Macular Edema Treatment Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Macular Edema Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Macular Edema Treatment Market Size (2016-2027)
6.2 North America Diabetic Macular Edema Treatment Market Size by Type
6.2.1 North America Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
6.2.2 North America Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
6.2.3 North America Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
6.3 North America Diabetic Macular Edema Treatment Market Size by Application
6.3.1 North America Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
6.3.2 North America Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
6.3.3 North America Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
6.4 North America Diabetic Macular Edema Treatment Market Size by Country
6.4.1 North America Diabetic Macular Edema Treatment Market Size by Country (2016-2021)
6.4.2 North America Diabetic Macular Edema Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diabetic Macular Edema Treatment Market Size (2016-2027)
7.2 Europe Diabetic Macular Edema Treatment Market Size by Type
7.2.1 Europe Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
7.3 Europe Diabetic Macular Edema Treatment Market Size by Application
7.3.1 Europe Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
7.4 Europe Diabetic Macular Edema Treatment Market Size by Country
7.4.1 Europe Diabetic Macular Edema Treatment Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Macular Edema Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Macular Edema Treatment Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type
8.2.1 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application
8.3.1 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Region
8.4.1 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Macular Edema Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Macular Edema Treatment Market Size (2016-2027)
9.2 Latin America Diabetic Macular Edema Treatment Market Size by Type
9.2.1 Latin America Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
9.3 Latin America Diabetic Macular Edema Treatment Market Size by Application
9.3.1 Latin America Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
9.4 Latin America Diabetic Macular Edema Treatment Market Size by Country
9.4.1 Latin America Diabetic Macular Edema Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Macular Edema Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Macular Edema Treatment Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type
10.2.1 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application
10.3.1 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Country
10.4.1 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Macular Edema Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genentech
11.1.1 Genentech Company Details
11.1.2 Genentech Business Overview
11.1.3 Genentech Diabetic Macular Edema Treatment Introduction
11.1.4 Genentech Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.1.5 Genentech Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Diabetic Macular Edema Treatment Introduction
11.2.4 Novartis Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Diabetic Macular Edema Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.3.5 GlaxoSmithKline Recent Development
11.4 Eyetech Pharmaceuticals
11.4.1 Eyetech Pharmaceuticals Company Details
11.4.2 Eyetech Pharmaceuticals Business Overview
11.4.3 Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Introduction
11.4.4 Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.4.5 Eyetech Pharmaceuticals Recent Development
11.5 Alimera Sciences
11.5.1 Alimera Sciences Company Details
11.5.2 Alimera Sciences Business Overview
11.5.3 Alimera Sciences Diabetic Macular Edema Treatment Introduction
11.5.4 Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2016-2021)
11.5.5 Alimera Sciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diabetic Macular Edema Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Laser Photocoagulation Therapy
Table 3. Key Players of Pharmacological Therapy
Table 4. Key Players of Bevacizumab
Table 5. Key Players of Ranibizumab
Table 6. Key Players of Triamcinolone
Table 7. Global Diabetic Macular Edema Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diabetic Macular Edema Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Diabetic Macular Edema Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Diabetic Macular Edema Treatment Market Share by Regions (2016-2021)
Table 11. Global Diabetic Macular Edema Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Diabetic Macular Edema Treatment Market Share by Regions (2022-2027)
Table 13. Diabetic Macular Edema Treatment Market Trends
Table 14. Diabetic Macular Edema Treatment Market Drivers
Table 15. Diabetic Macular Edema Treatment Market Challenges
Table 16. Diabetic Macular Edema Treatment Market Restraints
Table 17. Global Diabetic Macular Edema Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Diabetic Macular Edema Treatment Market Share by Players (2016-2021)
Table 19. Global Top Diabetic Macular Edema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Macular Edema Treatment as of 2020)
Table 20. Ranking of Global Top Diabetic Macular Edema Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Diabetic Macular Edema Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Diabetic Macular Edema Treatment Product Solution and Service
Table 24. Date of Enter into Diabetic Macular Edema Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Diabetic Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Diabetic Macular Edema Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Diabetic Macular Edema Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Diabetic Macular Edema Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Diabetic Macular Edema Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Diabetic Macular Edema Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Diabetic Macular Edema Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Diabetic Macular Edema Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Diabetic Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Diabetic Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Diabetic Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Diabetic Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Diabetic Macular Edema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Diabetic Macular Edema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Diabetic Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Diabetic Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Diabetic Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Diabetic Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Diabetic Macular Edema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Diabetic Macular Edema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diabetic Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Diabetic Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Diabetic Macular Edema Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Diabetic Macular Edema Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Diabetic Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Diabetic Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Diabetic Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Diabetic Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Diabetic Macular Edema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Diabetic Macular Edema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diabetic Macular Edema Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Diabetic Macular Edema Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Diabetic Macular Edema Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Diabetic Macular Edema Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Genentech Company Details
Table 65. Genentech Business Overview
Table 66. Genentech Diabetic Macular Edema Treatment Product
Table 67. Genentech Revenue in Diabetic Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 68. Genentech Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Diabetic Macular Edema Treatment Product
Table 72. Novartis Revenue in Diabetic Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. GlaxoSmithKline Company Details
Table 75. GlaxoSmithKline Business Overview
Table 76. GlaxoSmithKline Diabetic Macular Edema Treatment Product
Table 77. GlaxoSmithKline Revenue in Diabetic Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 78. GlaxoSmithKline Recent Development
Table 79. Eyetech Pharmaceuticals Company Details
Table 80. Eyetech Pharmaceuticals Business Overview
Table 81. Eyetech Pharmaceuticals Diabetic Macular Edema Treatment Product
Table 82. Eyetech Pharmaceuticals Revenue in Diabetic Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 83. Eyetech Pharmaceuticals Recent Development
Table 84. Alimera Sciences Company Details
Table 85. Alimera Sciences Business Overview
Table 86. Alimera Sciences Diabetic Macular Edema Treatment Product
Table 87. Alimera Sciences Revenue in Diabetic Macular Edema Treatment Business (2016-2021) & (US$ Million)
Table 88. Alimera Sciences Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Macular Edema Treatment Market Share by Type: 2020 VS 2027
Figure 2. Laser Photocoagulation Therapy Features
Figure 3. Pharmacological Therapy Features
Figure 4. Bevacizumab Features
Figure 5. Ranibizumab Features
Figure 6. Triamcinolone Features
Figure 7. Global Diabetic Macular Edema Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Ophthalmic Clinics Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Contract Research Organizations Case Studies
Figure 12. Diabetic Macular Edema Treatment Report Years Considered
Figure 13. Global Diabetic Macular Edema Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Diabetic Macular Edema Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Diabetic Macular Edema Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Diabetic Macular Edema Treatment Market Share by Regions (2022-2027)
Figure 17. Global Diabetic Macular Edema Treatment Market Share by Players in 2020
Figure 18. Global Top Diabetic Macular Edema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Macular Edema Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Diabetic Macular Edema Treatment Revenue in 2020
Figure 20. Global Diabetic Macular Edema Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Diabetic Macular Edema Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Diabetic Macular Edema Treatment Market Share by Type (2016-2027)
Figure 24. North America Diabetic Macular Edema Treatment Market Share by Application (2016-2027)
Figure 25. North America Diabetic Macular Edema Treatment Market Share by Country (2016-2027)
Figure 26. United States Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Diabetic Macular Edema Treatment Market Share by Type (2016-2027)
Figure 30. Europe Diabetic Macular Edema Treatment Market Share by Application (2016-2027)
Figure 31. Europe Diabetic Macular Edema Treatment Market Share by Country (2016-2027)
Figure 32. Germany Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Diabetic Macular Edema Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Diabetic Macular Edema Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Diabetic Macular Edema Treatment Market Share by Region (2016-2027)
Figure 42. China Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Diabetic Macular Edema Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Diabetic Macular Edema Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Diabetic Macular Edema Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Diabetic Macular Edema Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Diabetic Macular Edema Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Diabetic Macular Edema Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Diabetic Macular Edema Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Genentech Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2016-2021)
Figure 64. Eyetech Pharmaceuticals Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2016-2021)
Figure 65. Alimera Sciences Revenue Growth Rate in Diabetic Macular Edema Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【掲載企業】

Genentech、Novartis、GlaxoSmithKline、Eyetech Pharmaceuticals、Alimera Sciences

★調査レポート[世界の糖尿病黄斑浮腫治療市場規模・現状・予測2021-2027] (コード:QY21APR1834)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の糖尿病黄斑浮腫治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆